Navigation Links
Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
Date:8/18/2011

notherapy.  One of its platform technologies relies on inhibition of expression of the Ii protein.  Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forwar
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... DALLAS , July 3, 2015 ... report "Cardiac Monitoring & Cardiac Rhythm Management Market ... Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber ... published by MarketsandMarkets, the global Cardiac Monitoring (CM) ... poised to reach $26,646.5 Million by 2020 from ...
(Date:7/3/2015)... Mexique, July 3, 2015 ... les épidémies que sont l,hypertension, le diabète et ... de plateformes éducatives gratuites et d,une conférence majeure ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les ... ligne , Prendre en charge l,hypertension en ...
(Date:7/3/2015)... HUATULCO, Mexico , July 3, 2015 ... targeting the epidemics of hypertension, diabetes and thyroid disorders ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Combating Three Major Chronic Diseases in Latin America With Medical Education 2
... March 5, 2012  Sono-Tek Corporation (OTC BB: SOTK.pk) completed ... record preliminary results. Sales were approximately $12,000,000, an increase ... income is expected to be approximately $1,200,000, an increase ... $594,000 and above our goal of $1,000,000. Sono-Tek will ...
... 5, 2012  CVS Caremark (NYSE: CVS ) today ... and chief medical officer of the company, has been named ... , an independent commission that will assess how physicians ... care. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )   ...
Cached Medicine Technology:Sono-Tek Announces Record Year End Results 2CVS Caremark's Chief Medical Officer Troyen Brennan is Named to the National Commission on Physician Payment Reform 2
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer ... even minimal asbestos exposure. Click here to read the complete story , just ... Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice with a ...
(Date:7/3/2015)... ... , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod ... . To be held from March 4th - 6th, the 2016 (a previous announcement ... Dallas. , Designed to take participants from the basic training and fundamentals of nasal ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... exclusively to healthcare providers, has been retained to lead a national president ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... on June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy ... injured bicyclists and practical points of investigating these types of cases. , Each ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... veterans , , TUESDAY, March 24 (HealthDay News) -- Exposure ... to have triggered abnormal responses in the brains of ... the discovery could lead to new diagnostic tests and ... , The study, from the University of Texas Southwestern ...
... Omega-3 fatty acids appear protective against advanced prostate ... genetic variant in the COX-2 gene, according to a ... of the American Association for Cancer Research. , "Previous ... is one of the first studies to show protection ...
... the threat of tuberculosis and the toll it takes on ... , The TB-HIV co-infection crisis is twice as big ... there were at least 1.37 million cases of HIV-positive TBor ... the previous WHO estimates. , "A global health catastrophe ...
... Inc. (NYSE: CNO ) today announced that ... senior secured credit agreement. Banc of America Securities ... the amendment. The amendment, which does not seek ... repayment schedule, is expected to provide for, among other ...
... Cancer Action Network, the American Heart Association, the American ... Senator Frank Lautenberg of New Jersey,s call for the ... immediately remove e-cigarettes from the market. FDA officials ... the past few weeks saying that e-cigarettes are "new ...
... shown that an innovative anti-microbial catheter could vastly improve ... dialysis patients. , Results of a study published in ... the catheter has the potential to ward off attack ... Ambulatory Peritoneal Dialysis (CAPD) patients from infections for up ...
Cached Medicine News:Health News:Gulf War Syndrome May Stem From Chemical Exposure 2Health News:Alarming new data shows TB-HIV co-infection a bigger threat 2Health News:Conseco Seeks Amendment of Its Credit Facility 2Health News:Conseco Seeks Amendment of Its Credit Facility 3Health News:Conseco Seeks Amendment of Its Credit Facility 4Health News:Statement of the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free Kids 2Health News:Anti-microbial catheter to cut infection risk for dialysis patients 2Health News:Anti-microbial catheter to cut infection risk for dialysis patients 3
... is the Bard Kugel Patch, which is constructed ... two layers create a positioning pocket, which is ... position. On the other side is a barrier ... "memory recoil ring," which causes the patch to ...
... Bard mesh has become the standard against ... mesh was used by Dr. Irving Lichtenstein ... repair many years ago. Lichtenstein describes Bard ... for permanent reinforcement of hernia repair. As ...
... Visilex mesh is the first polypropylene ... repair. Visilex mesh directly addresses the ... More specifically, it delivers maximum visibility, ... profile after insertion through the trocar.,Visilex ...
... mesh is a three-dimensional, anatomically formed prosthesis ... Bard 3DMax mesh has been designed based ... the inguinal canal. The result is a ... Bard 3DMax product is constructed of Bard ...
Medicine Products: